nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Ablation of Gsα signaling in osteoclast progenitor cells adversely affects skeletal bone maintenance
|
Ramaswamy, Girish |
|
2018 |
109 |
C |
p. 86-90 |
artikel |
2 |
A case report of mesenteric heterotopic ossification: Histopathologic and genetic findings
|
Amalfitano, Matthew |
|
2018 |
109 |
C |
p. 56-60 |
artikel |
3 |
Activin A amplifies dysregulated BMP signaling and induces chondro-osseous differentiation of primary connective tissue progenitor cells in patients with fibrodysplasia ossificans progressiva (FOP)
|
Wang, Haitao |
|
2018 |
109 |
C |
p. 218-224 |
artikel |
4 |
Acute and chronic rapamycin use in patients with Fibrodysplasia Ossificans Progressiva: A report of two cases
|
Kaplan, Frederick S. |
|
2018 |
109 |
C |
p. 281-284 |
artikel |
5 |
Acute unilateral hip pain in fibrodysplasia ossificans progressiva (FOP)
|
Kaplan, Frederick S. |
|
2018 |
109 |
C |
p. 115-119 |
artikel |
6 |
Application of human induced pluripotent stem cells to model fibrodysplasia ossificans progressiva
|
Barruet, Emilie |
|
2018 |
109 |
C |
p. 162-167 |
artikel |
7 |
Cartilage-derived retinoic acid-sensitive protein (CD-RAP): A stage-specific biomarker of heterotopic endochondral ossification (HEO) in fibrodysplasia ossificans progressiva (FOP)
|
Lindborg, Carter M. |
|
2018 |
109 |
C |
p. 153-157 |
artikel |
8 |
Circulating osteogentic precursor cells in non-hereditary heterotopic ossification
|
Egan, Kevin P. |
|
2018 |
109 |
C |
p. 61-64 |
artikel |
9 |
Clinical-pathological correlations in three patients with fibrodysplasia ossificans progressiva
|
Wentworth, Kelly L. |
|
2018 |
109 |
C |
p. 104-110 |
artikel |
10 |
Clinical staging of Fibrodysplasia Ossificans Progressiva (FOP)
|
Pignolo, Robert J. |
|
2018 |
109 |
C |
p. 111-114 |
artikel |
11 |
Conserved signaling pathways underlying heterotopic ossification
|
Kan, Chen |
|
2018 |
109 |
C |
p. 43-48 |
artikel |
12 |
Drosophila models of FOP provide mechanistic insight
|
Le, Viet |
|
2018 |
109 |
C |
p. 192-200 |
artikel |
13 |
Early clinical observations on the use of imatinib mesylate in FOP: A report of seven cases
|
Kaplan, Frederick S. |
|
2018 |
109 |
C |
p. 276-280 |
artikel |
14 |
ECSIT links TLR and BMP signaling in FOP connective tissue progenitor cells
|
Wang, Haitao |
|
2018 |
109 |
C |
p. 201-209 |
artikel |
15 |
Editorial Board
|
|
|
2018 |
109 |
C |
p. i-ii |
artikel |
16 |
Fibrodysplasia ossificans progressiva in China
|
She, Dunmin |
|
2018 |
109 |
C |
p. 101-103 |
artikel |
17 |
Fibrodysplasia ossificans progressiva: The patient voice
|
Cali, Ian L. |
|
2018 |
109 |
C |
p. 291-294 |
artikel |
18 |
[18F]NaF PET/CT scan as an early marker of heterotopic ossification in fibrodysplasia ossificans progressiva
|
Eekhoff, E. Marelise W. |
|
2018 |
109 |
C |
p. 143-146 |
artikel |
19 |
Gli1-labeled adult mesenchymal stem/progenitor cells and hedgehog signaling contribute to endochondral heterotopic ossification
|
Kan, Chen |
|
2018 |
109 |
C |
p. 71-79 |
artikel |
20 |
GNAS mutations and heterotopic ossification
|
Bastepe, Murat |
|
2018 |
109 |
C |
p. 80-85 |
artikel |
21 |
Heterotopic bone induction via BMP signaling: Potential therapeutic targets for fibrodysplasia ossificans progressiva
|
Katagiri, Takenobu |
|
2018 |
109 |
C |
p. 241-250 |
artikel |
22 |
Heterotopic ossification and lessons learned from fifteen years at war: A review of therapy, novel research, and future directions for military and civilian orthopaedic trauma
|
Hoyt, Benjamin W. |
|
2018 |
109 |
C |
p. 3-11 |
artikel |
23 |
Heterotopic ossification and the elucidation of pathologic differentiation
|
Cholok, David |
|
2018 |
109 |
C |
p. 12-21 |
artikel |
24 |
Heterotopic ossification: Mechanistic insights and clinical challenges
|
Xu, Ruoshi |
|
2018 |
109 |
C |
p. 134-142 |
artikel |
25 |
Heterotopic Ossification: The Keys to the Kingdom
|
Kaplan, Frederick S. |
|
2018 |
109 |
C |
p. 1-2 |
artikel |
26 |
High-frequency spectral ultrasound imaging (SUSI) visualizes early post-traumatic heterotopic ossification (HO) in a mouse model
|
Ranganathan, Kavitha |
|
2018 |
109 |
C |
p. 49-55 |
artikel |
27 |
Hints on transcriptional control of essential players in heterotopic ossification of Fibrodysplasia Ossificans Progressiva
|
Ravazzolo, Roberto |
|
2018 |
109 |
C |
p. 187-191 |
artikel |
28 |
Histopathology of periarticular non-hereditary heterotopic ossification
|
Foley, Kristin L. |
|
2018 |
109 |
C |
p. 65-70 |
artikel |
29 |
Imaging assessment of fibrodysplasia ossificans progressiva: Qualitative, quantitative and questionable
|
Al Mukaddam, Mona |
|
2018 |
109 |
C |
p. 147-152 |
artikel |
30 |
Is heterotopic ossification getting nervous?: The role of the peripheral nervous system in heterotopic ossification
|
Davis, Eleanor L. |
|
2018 |
109 |
C |
p. 22-27 |
artikel |
31 |
Joint-specific risk of impaired function in fibrodysplasia ossificans progressiva (FOP)
|
Pignolo, Robert J. |
|
2018 |
109 |
C |
p. 124-133 |
artikel |
32 |
Longitudinal patient-reported mobility assessment in fibrodysplasia ossificans progressiva (FOP)
|
Kaplan, Frederick S. |
|
2018 |
109 |
C |
p. 158-161 |
artikel |
33 |
Mast cell inhibition as a therapeutic approach in fibrodysplasia ossificans progressiva (FOP)
|
Brennan, Tracy A. |
|
2018 |
109 |
C |
p. 259-266 |
artikel |
34 |
Neurological heterotopic ossification: Current understanding and future directions
|
Brady, Rhys D. |
|
2018 |
109 |
C |
p. 35-42 |
artikel |
35 |
Periodontal ligament fibroblasts as a cell model to study osteogenesis and osteoclastogenesis in fibrodysplasia ossificans progressiva
|
de Vries, Teun J. |
|
2018 |
109 |
C |
p. 168-177 |
artikel |
36 |
Prevalence and risk factors for kidney stones in fibrodysplasia ossificans progressiva
|
Gupta, Rishi R. |
|
2018 |
109 |
C |
p. 120-123 |
artikel |
37 |
Retinoid roles and action in skeletal development and growth provide the rationale for an ongoing heterotopic ossification prevention trial
|
Pacifici, Maurizio |
|
2018 |
109 |
C |
p. 267-275 |
artikel |
38 |
Shared ACVR1 mutations in FOP and DIPG: Opportunities and challenges in extending biological and clinical implications across rare diseases
|
Han, Harry J. |
|
2018 |
109 |
C |
p. 91-100 |
artikel |
39 |
Stem cells and heterotopic ossification: Lessons from animal models
|
Lees-Shepard, John B. |
|
2018 |
109 |
C |
p. 178-186 |
artikel |
40 |
Structural basis for the potent and selective binding of LDN-212854 to the BMP receptor kinase ALK2
|
Williams, Eleanor |
|
2018 |
109 |
C |
p. 251-258 |
artikel |
41 |
The FOP Connection Registry: Design of an international patient-sponsored registry for Fibrodysplasia Ossificans Progressiva
|
Mantick, Neal |
|
2018 |
109 |
C |
p. 285-290 |
artikel |
42 |
The obligatory role of Activin A in the formation of heterotopic bone in Fibrodysplasia Ossificans Progressiva
|
Alessi Wolken, Dana M. |
|
2018 |
109 |
C |
p. 210-217 |
artikel |
43 |
Variable signaling activity by FOP ACVR1 mutations
|
Haupt, Julia |
|
2018 |
109 |
C |
p. 232-240 |
artikel |
44 |
Variant BMP receptor mutations causing fibrodysplasia ossificans progressiva (FOP) in humans show BMP ligand-independent receptor activation in zebrafish
|
Mucha, Bettina E. |
|
2018 |
109 |
C |
p. 225-231 |
artikel |
45 |
Vascular ossification: Pathology, mechanisms, and clinical implications
|
Fuery, Michael A. |
|
2018 |
109 |
C |
p. 28-34 |
artikel |